[Investor Updates]PharmAbcine, non-confidential slide deck Q3 2022

28 Jul 2022
제목PharmAbcine, non-confidential slide deck Q3 2022

Notice of Changes:

1. Updates on status of clinical activities

2. Potential market size of each pipeline’s indications

3. Addition of new preclinical data at AACR 2022 and BIO USA 2022. (PMC-309)

4. Future milestones of the Company’s R&D activities

Please check the attached file for details.

We would like to thank our shareholders, investors, and partners for their continued support.

     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea

     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 

     COPYRIGHT BY PharmAbcine Inc.